Chemoinformaics analysis of 18-Hydroxyoctadecanoic acid
Molecular Weight | 300.483 | nRot | 17 |
Heavy Atom Molecular Weight | 264.195 | nRig | 1 |
Exact Molecular Weight | 300.266 | nRing | 0 |
Solubility: LogS | -3.871 | nHRing | 0 |
Solubility: LogP | 6.011 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 57 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 36 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 56.4705 |
nHD | 2 | BPOL | 36.9835 |
QED | 0.358 |
Synth | 1.725 |
Natural Product Likeliness | 0.466 |
NR-PPAR-gamma | 0.975 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Accepted |
Pgp-inh | 0.004 |
Pgp-sub | 0 |
HIA | 0.011 |
CACO-2 | -5.261 |
MDCK | 0.0000298 |
BBB | 0.15 |
PPB | 0.976795 |
VDSS | 0.627 |
FU | 0.0106284 |
CYP1A2-inh | 0.196 |
CYP1A2-sub | 0.162 |
CYP2c19-inh | 0.099 |
CYP2c19-sub | 0.056 |
CYP2c9-inh | 0.139 |
CYP2c9-sub | 0.988 |
CYP2d6-inh | 0.003 |
CYP2d6-sub | 0.041 |
CYP3a4-inh | 0.018 |
CYP3a4-sub | 0.014 |
CL | 2.874 |
T12 | 0.695 |
hERG | 0.062 |
Ames | 0.005 |
ROA | 0.016 |
SkinSen | 0.932 |
Carcinogencity | 0.074 |
EI | 0.974 |
Respiratory | 0.651 |
NR-Aromatase | 0.191 |
Antiviral | No |
Prediction | 0.58312 |